CDC issues new guide for tick-borne rickettsial diseases
A new guide has been published by the CDC in part to aid clinicians with the difficult task of diagnosing tick-borne rickettsial diseases (TBRDs). According to the agency, the incidence of these diseases has risen in the past 10 years, causing severe illness and death in adults and children in the United States despite the fact that the conditions are easily treated with antibiotics in the early stages.
CDC issues new guide for tick-borne rickettsial diseases
A new guide has been published by the CDC in part to aid clinicians with the difficult task of diagnosing tick-borne rickettsial diseases (TBRDs). According to the agency, the incidence of these diseases has risen in the past 10 years, causing severe illness and death in adults and children in the United States despite the fact that the conditions are easily treated with antibiotics in the early stages. CDC's Viral and Rickettsial Zoonoses Branch, along with 11 other specialists of Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis, prepared the new document, which focuses on the epidemiology, clinical assessment, treatment, and laboratory diagnosis of TBRDs. Pharmacists can access the report at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
